Epstein-Barr Virus (LMP)
EB100
Overview
- SupplierNordic-MUbio
- Product NameEpstein-Barr Virus (LMP)
- Delivery Days Customer7
- ApplicationsImmunoHistoChemistry
- Applications SupplierImmunohistochemistry (frozen);Immunohistochemistry (paraffin);Immunohistochemistry (frozen);Immunohistochemistry (paraffin)
- Category SupplierPrimary Antibodies
- CertificationResearch Use Only
- Clone IDCS1-4 Cocktail
- Concentration50 ug/ml
- HostMouse
- IsotypeIgG1
- Reactivity Supplier NoteFusion protein of beta-galactosidase and EBV-late membrane antigen
- Storage Instruction2-8°C
- UNSPSC12352203
References
- 1. Rowe M., Rowe D.T., Gregory C.D., Young L.S., Farrell P.J., Rupani H., et al. (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma. EMBO J. 6; 2743-2453. 2. 2. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., et al. (1990) Epstein-Barr virus in nasal T-cell lymphomaas in patients with lethal midline granuloma. Lancet 335; 128-130. 3. Herbst H. Dallenbach F. Hummel M., Niedobietek G. Finn T., Young L.S., et al. (19919 Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphoma. 4. Murray P.G., Young L.S., Rowe M., and Crocker J. (1992) Immunohistochemical demonstration of the Epstein-Barr virus encoded latent membrane protein in paraffin sections of Hodgkin's disease. J. Pathol. 166; 1-5.